GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Span Divergent Ltd-$

Span Divergent Q2 FY27 Standalone Loss: (27.06) Lakhs, Preferential Issue Fully Utilised

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 05 Nov 2026, 07:32 PM IST  ·  BSE ID: 7187b8a5-386e-49bd-9bc2-45adc45aab45
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a standalone loss for the quarter and fully used funds from a March 2026 share sale.
🤖 AI Summary
  • Span Divergent reported a standalone loss of (27.06) Rs. In Lakhs for Q2 FY27, down from a profit of 12.01 Rs. In Lakhs in Q2 FY26.
  • Total standalone income for Q2 FY27 was 36.46 Rs. In Lakhs, compared to 55.84 Rs. In Lakhs in Q2 FY26.
  • The company confirmed full utilisation of 579.36 Rs. In Lakhs from the Preferential Issue, raised in March 2026, for its stated objects.
  • Subsidiary Biospan Contamination Control Solution Pvt. Ltd. had total liabilities exceeding assets by (759) Rs. In Lakhs as of September 30, 2026.
  • Accumulated losses for Aranya Consulting and Biotech LLP reached 1495 Rs. In Lakhs by March 31, 2026, with an additional (1.37) Rs. In Lakhs loss by September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Standalone Profit/(Loss) for the period after tax Q2 FY27
(27.06) Rs. In Lakhs
Not comparable — limited prior period data.
Standalone Total Income Q2 FY27
36.46 Rs. In Lakhs
Not comparable — limited prior period data.
Preferential Issue Amount Raised
579.36 Rs. In Lakhs
Biospan Contamination Control Solution Pvt. Ltd. Liabilities exceeding assets (September 30, 2026)
(759) Rs. In Lakhs
Standalone Total Equity September 30, 2026
4,093.21 Rs. In Lakhs
Standalone Total Liabilities September 30, 2026
611.23 Rs. In Lakhs
🏢 How This Affects the Company
📈
Business Impact
The ongoing losses in key LLP subsidiaries and the negative net worth of a subsidiary indicate challenges in achieving profitable operations, despite management's stated plans for revival.
💰
Financial Impact
The standalone loss for Q2 FY27 of (27.06) Rs. In Lakhs contributes to half-year losses of (31.29) Rs. In Lakhs, impacting overall profitability. The full utilization of preferential issue funds eliminates future capital raising for those specific objects.
⚙️
Operational Impact
Management's decision to revive Aranya Consulting and Biotech LLP operations and reclassify assets as PPE suggests a renewed focus on specific business segments. Plans to explore tie-ups for Biospan Scientific LLP also reflect operational adjustments.
⚠️
Risk Impact
Accumulated losses and negative net worth in subsidiaries, specifically Biospan Contamination Control Solution Pvt. Ltd. with liabilities exceeding assets by (759) Rs. In Lakhs, present significant financial risks to the parent company. Continued reliance on a going concern basis for these subsidiaries without clear turnaround evidence adds to risk.
👥 What This Means For Shareholders
✅
Action Required
No action required based on this filing.
👤
Who Is Affected
All shareholders are indirectly affected by the company's standalone financial performance and the financial health of its subsidiaries. The full utilisation of preferential issue funds impacts expectations for future capital deployment.
🔍
Management Signal
Management is signalling intent to revive non-operational subsidiaries and pursue business tie-ups, while also confirming completion of fund utilisation for the March 2026 Preferential Issue.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — monitor standalone profitability trend and subsidiary performance.
Updates on revival plans for Aranya Consulting and Biotech LLP and Biospan Scientific LLP.
Any further disclosures regarding the financial health of Biospan Contamination Control Solution Pvt. Ltd.
HIGH RISK Standalone losses and significant financial distress in multiple subsidiaries present substantial operational and financial risks.
💡 Investor Takeaway
Span Divergent reported a standalone loss after tax of (27.06) Rs. In Lakhs for Q2 FY27, contrasting with a profit of 12.01 Rs. In Lakhs in Q2 FY26. The Preferential Issue funds of 579.36 Rs. In Lakhs from March 2026 have been fully utilised as per objects.
⚖️ Strengths & Concerns

✅ Positives

  • Full utilisation of 579.36 Rs. In Lakhs from the Preferential Issue in March 2026 confirms adherence to stated funding objects without deviation.
  • Standalone other comprehensive income for Q2 FY27 was 3.28 Rs. In Lakhs, contributing positively to total comprehensive income.

⚠️ Concerns

  • Span Divergent reported a standalone loss after tax of (27.06) Rs. In Lakhs for Q2 FY27, a decline from a profit of 12.01 Rs. In Lakhs in Q2 FY26.
  • Subsidiary Biospan Contamination Control Solution Pvt. Ltd.'s liabilities exceeded its total assets by (759) Rs. In Lakhs as of September 30, 2026, indicating significant financial stress.
📅 Company Track Record
Span Divergent Limited (formerly Span Diagnostics Ltd.) previously approved Q2 FY27 results, a ₹5,68,00,000/- corporate guarantee, and a ₹5,00,00,000/- property sale in a Board Meeting on November 05, 2026, coinciding with this results announcement.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Span Divergent Ltd.'s standalone net profit/loss for Q2 FY27?
Span Divergent Ltd. reported a standalone loss after tax of (27.06) Rs. In Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the total standalone income for Span Divergent Ltd. in Q2 FY27?
The total standalone income for Span Divergent Ltd. for the quarter ended September 30, 2026 (Q2 FY27) was 36.46 Rs. In Lakhs.
Has Span Divergent Ltd. utilised funds from its March 2026 Preferential Issue?
Yes, Span Divergent Ltd. confirmed the full utilisation of 579.36 Rs. In Lakhs from its Preferential Issue, raised in March 2026, for the specified objects.
What is the financial situation of Span Divergent Ltd.'s subsidiary Biospan Contamination Control Solution Pvt. Ltd. as of September 30, 2026?
As of September 30, 2026, Biospan Contamination Control Solution Pvt. Ltd. had total liabilities exceeding its total assets by (759) Rs. In Lakhs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.